Want to track LUNG and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Pulmonx Corporation (LUNG) Statistics
Valuation metrics
Market Cap 62.51M
Enterprise value 53.85M
Trailing P/E (ttm) -1.08
Forward P/E -1.42
PEG ratio -0.1
Price/Sales (ttm) 0.67
Price/Book (mrq) 1.28
Enterprise Value/Revenue 0.61
Enterprise Value/EBITDA -1.12
Overview
Shares outstanding 42.24M
Float 37.27M
Shares short 3.56M
% Held by insiders 0.05%
% Held by institutions 0.78%
Average volume (10 days) 116.61K
Average volume (90 days) 608.14K
Price summary
52-Week low 1.13
52-Week high 3.88
Beta 0.18
50-Day moving average 1.36
200-Day moving average 1.54
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -0.6%
Operating margin -0.59%
Operational effectiveness
Return on assets -0.44%
Return on equity -0.93%
Income Statement
Revenue (ttm) 88.55M
Revenue per share (ttm) 2.11
Quarterly revenue growth (yoy) -0.09%
Gross profit (ttm) 66.84M
EBITDA -51.16M
Net income to common (ttm) -53.21M
Diluted EPS (ttm) -1.27
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 61.57M
Total cash per share (mrq) 1.47
Total debt (mrq) 56.29M
Total Debt/Equity (mrq) 1.23
Current ratio (mrq) 4.91%
Book value per share (mrq) 1.09
Cash Flow
Cash flow statement -29.25M
Levered free cash flow (LFCF) -8.36M
